Market Research Logo

Global Cell and Tissue Technologies Market Insights, Opportunity, Analysis, Market Shares and Forecast 2016 – 2022

Global Cell and Tissue Technologies Market Insights, Opportunity, Analysis, Market Shares and Forecast 2016 – 2022

The global cell and tissue technology market is expected to grow at the CAGR of 6.56% during 2016-2022. The market has generated revenue more than $19 billion in 2016 and is projected to reach up to $30 billion by 2022. Due to increasing chronic cases and inferior’s diseases, increasing health industry, increasing advanced technology products and increasing government and private funding for cell based research act as the major factors which increase the market of cell and tissue technology globally. The key drivers which accelerate the market are rising cancer cases. According to World Health Organization, the cancer rate is increasing to reach to 15 million new cases by 2020. According to WHO report, more than 1.2 million new cases are diagnosed for lung cancer worldwide, one million new cases of breast, 870000 cases of stomach, 560000 cases of cervical, 410000 cases of head and neck cancer and many more. Due to these cases, the demand of cell and tissue technology has increased.

The cell and tissue technology is segmented on the basis of product, process and end users. On the basis of product, the market is segmented as consumables and instruments. The consumable is further sub segmented in to reagents, assay kits, microplates and other consumables. The instruments are further segmented as microscopes, flow cytometry, spectrophotometers, QPCR, cell counters, high-content screening (HCS) systems and cell microarrays. The microscopes are further sub segmented in to electron microscopes, inverted microscopes, stereo microscopes, fluorescence and confocal microscopes, phase contrast microscopes, near-field scanning optical microscopes (NSOM), and other microscopes. The flow cytometer is further sub segmented as flow cytometer instruments and flow cytometer software. The spectrophotometer is further sub segmented as fluorescence micro plate readers, colorimeters, micro plate spectrophotometer. The cell counters is further sub segmented as automated cell counters and hem cytometers and manual cell counters. The high-content screening (HCS) systems are further sub segmented as cell imaging and technology HCS systems and HCS software. On the basis of process, the market is further segmented as cell signaling pathways/signal transduction, cell proliferation, cell number counting and quality control, cell interaction, cell structure study, target identification and validation and single-cell technology. On the basis of end users, the market is further segmented as hospitals and academic & research institutes, laboratories, contract research organizations (CROS) and pharmaceutical & biotechnology companies, cell culture collection repositories and other end users.

Geographically, the cell and tissue technology market is divided into North America, Europe, Asia Pacific, and Rest of the World. North America has the largest market share of cell and tissue technology followed by Europe and Asia Pacific. The APAC regions have a trend of developing market and various opportunities of growth in China, Japan, Australia, and India and are likely to have huge investments for new investors in the cell and tissue technology market. Drug discovery services outsourcing and government aided funding for novel screening technologies has resulted in growth of Asian markets.

Some of the major market players are Agilent Technologies, Inc., Becton, Dickinson and Company, Bio-Rad Laboratories, Danaher Corporation, Fluidigm Corporation, GE Healthcare, Merck KGAA, Nanostring Technologies, Inc., Olympus Corporation, Perkinelmer, Inc., Promega Corporation, Qiagen N.V., Sigma Aldrich Corporation, Tecan Group Ltd., Thermo Fisher Scientific, Inc. etc. Acquisition, mergers and expansions are the key strategies adopted by the market players to sustain in the market. For example, in November 2015, Agilent Technologies announced the completion of acquisition of Seahorse Bioscience, a leader in providing instruments and assay gears for measuring cell metabolism and bioenergetics. Similarly, in august 2015, Danaher Corporation declared the completion of acquisition of Pall Corporation, a New York based company, and a global supplier of filtration, separations and purification products.

Please note: The delivery time for the electronic version of this report is between 1-3 business days to allow the preparation of an updated version prior to dispatch.


1. INTRODUCTION
1.1. EXECUTIVE SUMMARY
1.2. ESTIMATION METHODOLOGY
2. MARKET OVERVIEW
2.1. MARKET DEFINITION AND SCOPE
2.2. KEY FINDINGS
2.3. PARAMETRIC TECHNOLOGIES
2.4. KEY MARKET INSIGHTS
2.4.1. TOP EMERGING COUNTRIES
2.4.2. TOP REVENUE GENERATING SEGMENTS
2.4.3. TOP GROWING MARKETS AND EMERGING TRENDS
2.4.4. TOP GEOGRAPHY
2.5. COMPETITIVE LANDSCAPE
2.5.1. MARKET SHARE TECHNOLOGIES
2.5.2. TOP WINNING STRATEGIES
2.5.3. CASE STUDIES: TOP COMPETITIVE MOVES
2.6. PORTER’S FIVE FORCE MODEL
2.6.1. THREAT OF NEW ENTRANTS
2.6.2. THREAT OF SUBSTITUTE PRODUCTS OR SERVICES
2.6.3. BARGAINING POWER OF BUYER
2.6.4. BARGAINING POWER OF SUPPLIER
2.6.5. INTENSITY OF COMPETITIVE RIVALRY
2.7. KEY BUYING CRITERIA
2.8. STRATEGIC RECOMMENDATION
2.9. STRATEGIC CONCLUSIONS
3. MARKET DETERMINANTS
3.1. MARKET DRIVERS
3.1.1. RISING CANCER CASES
3.1.2. INCREASING CASES OF CHRONIC AND INFERIORS DISEASES
3.1.3. INCREASING HEALTH INDUSTRY
3.1.4. INCREASING ADVANCED TECHNOLOGY PRODUCTS
3.1.5. INCREASING GOVERNMENT AND PRIVATE FUNDING FOR CELL BASED RESEARCH
3.2. MARKET RESTRAINTS
3.2.1. INCREASING COST OF CELL TECHNOLOGIES SYSTEM
3.2.2. COMPLEX AND TIME CONSUMING GUIDELINES INCREASE THE APPROVAL PROCESS
3.2.3. COGNITIVE PROPERTY RIGHT ISSUES RESTRICT INNOVATIONS IN ASSAY KITS
3.2.4. STRICT GOVERNMENT REGULATION FOR MEDICAL SECTOR
3.3. MARKET OPPORTUNITIES
3.3.1. INCREASING DEMAND IN EMERGING COUNTRIES
3.3.2. AUTOMATION IN CANCER RESEARCH
3.4. MARKET CHALLENGES
3.4.1. DEARTH OF SKILLED AND KNOWLEDGEABLE PROFESSIONALS
3.4.2. MARKET CANNIBALIZATION OF EXISTING TECHNOLOGIES BY NEW AND UPCOMING TECHNOLOGIES
3.5. PARENT MARKET
3.6. COMPETITORS MARKET
3.7. ALTERNATIVE MARKET
4. MARKET SEGMENTATION
4.1. BY PRODUCT
4.1.1. GLOBAL CELL AND TISSUE TECHNOLOGIES MARKET BY CONSUMABLES 2014-2022 ($ MILLION)
4.1.1.1. GLOBAL CELL AND TISSUE TECHNOLOGIES MARKET BY REAGENTS 2014-2022 ($ MILLION)
4.1.1.2. GLOBAL CELL AND TISSUE TECHNOLOGIES MARKET BY ASSAY KITS 2014-2022 ($ MILLION)
4.1.1.2.1. GLOBAL CELL AND TISSUE TECHNOLOGIES MARKET BY IMMUNOASSAYS 2014-2022 ($ MILLION)
4.1.1.2.2. GLOBAL CELL AND TISSUE TECHNOLOGIES MARKET BY CELL-BASED ASSAYS 2014-2022 ($ MILLION)
4.1.1.3. GLOBAL CELL AND TISSUE TECHNOLOGIES MARKET BY MICROPLATES 2014-2022 ($ MILLION)
4.1.1.4. GLOBAL CELL AND TISSUE TECHNOLOGIES MARKET BY OTHER CONSUMABLES 2014-2022 ($ MILLION)
4.1.2. GLOBAL CELL AND TISSUE TECHNOLOGIES MARKET BY INSTRUMENTS 2014-2022 ($ MILLION)
4.1.2.1. GLOBAL CELL AND TISSUE TECHNOLOGIES MARKET BY MICROSCOPES 2014-2022 ($ MILLION)
4.1.2.1.1. GLOBAL CELL AND TISSUE TECHNOLOGIES MARKET BY ELECTRON MICROSCOPES 2014-2022 ($ MILLION)
4.1.2.1.2. GLOBAL CELL AND TISSUE TECHNOLOGIES MARKET BYINVERTED MICROSCOPES 2014-2022 ($ MILLION)
4.1.2.1.3. GLOBAL CELL AND TISSUE TECHNOLOGIES MARKET BY STEREO MICROSCOPES 2014-2022 ($ MILLION)
4.1.2.1.4. GLOBAL CELL AND TISSUE TECHNOLOGIES MARKET BYFLUORESCENCE AND CONFOCAL MICROSCOPES 2014-2022 ($ MILLION)
4.1.2.1.5. GLOBAL CELL AND TISSUE TECHNOLOGIES MARKET BY PHASE CONTRAST MICROSCOPES 2014-2022 ($ MILLION)
4.1.2.1.6. GLOBAL CELL AND TISSUE TECHNOLOGIES MARKET BY NEAR-FIELD SCANNING OPTICAL MICROSCOPES (NSOM) 2014-2022 ($ MILLION)
4.1.2.1.7. GLOBAL CELL AND TISSUE TECHNOLOGIES MARKET BY OTHER MICROSCOPES 2014-2022 ($ MILLION)
4.1.2.2. GLOBAL CELL AND TISSUE TECHNOLOGIES MARKET BY FLOW CYTOMETRY 2014-2022 ($ MILLION)
4.1.2.2.1. GLOBAL CELL AND TISSUE TECHNOLOGIES MARKET BY FLOW CYTOMETER SOFTWARE 2014-2022 ($ MILLION)
4.1.2.2.2. GLOBAL CELL AND TISSUE TECHNOLOGIES MARKET BY FLOW CYTOMETER INSTRUMENTS 2014-2022 ($ MILLION)
4.1.2.3. GLOBAL CELL AND TISSUE TECHNOLOGIES MARKET BY SPECTROPHOTOMETERS 2014-2022 ($ MILLION)
4.1.2.3.1. GLOBAL CELL AND TISSUE TECHNOLOGIES MARKET BY MICRO PLATE SPECTROPHOTOMETERS 2014-2022 ($ MILLION)
4.1.2.3.2. GLOBAL CELL AND TISSUE TECHNOLOGIES MARKET BY COLORIMETERS 2014-2022 ($ MILLION)
4.1.2.3.3. GLOBAL CELL AND TISSUE TECHNOLOGIES MARKET BY FLUORESCENCE MICRO PLATE READERS 2014-2022 ($ MILLION)
4.1.2.4. GLOBAL CELL AND TISSUE TECHNOLOGIES MARKET BY QPCR 2014-2022 ($ MILLION)
4.1.2.5. GLOBAL CELL AND TISSUE TECHNOLOGIES MARKET BY CELL COUNTERS 2014-2022 ($ MILLION)
4.1.2.5.1. GLOBAL CELL AND TISSUE TECHNOLOGIES MARKET BY HEM CYTOMETERS AND MANUAL CELL COUNTERS 2014-2022 ($ MILLION)
4.1.2.5.2. GLOBAL CELL AND TISSUE TECHNOLOGIES MARKET BY AUTOMATED CELL COUNTERS 2014-2022 ($ MILLION)
4.1.2.6. GLOBAL CELL AND TISSUE TECHNOLOGIES MARKET BY HIGH-CONTENT SCREENING (HCS) SYSTEMS 2014-2022 ($ MILLION)
4.1.2.6.1. GLOBAL CELL AND TISSUE TECHNOLOGIES MARKET BY HCS SOFTWARE 2014-2022 ($ MILLION)
4.1.2.6.2. GLOBAL CELL AND TISSUE TECHNOLOGIES MARKET BY CELL IMAGING AND TECHNOLOGIES HCS SYSTEMS 2014-2022 ($ MILLION)
4.1.2.7. GLOBAL CELL AND TISSUE TECHNOLOGIES MARKET BY CELL MICROARRAYS 2014-2022 ($ MILLION)
4.2. BY PROCESS
4.2.1. GLOBAL CELL AND TISSUE TECHNOLOGIES MARKET BY SINGLE-CELL TECHNOLOGIES 2014-2022 ($ MILLION)
4.2.2. GLOBAL CELL AND TISSUE TECHNOLOGIES MARKET BY TARGET IDENTIFICATION AND VALIDATION 2014-2022 ($ MILLION)
4.2.3. GLOBAL CELL AND TISSUE TECHNOLOGIES MARKET BY CELL STRUCTURE STUDY 2014-2022 ($ MILLION)
4.2.4. GLOBAL CELL AND TISSUE TECHNOLOGIES MARKET BY CELL INTERACTION 2014-2022 ($ MILLION)
4.2.5. GLOBAL CELL AND TISSUE TECHNOLOGIES MARKET BY CELL COUNTING AND QUALITY CONTROL 2014-2022 ($ MILLION)
4.2.6. GLOBAL CELL AND TISSUE TECHNOLOGIES MARKET BY CELL PROLIFERATION 2014-2022 ($ MILLION)
4.2.7. GLOBAL CELL AND TISSUE TECHNOLOGIES MARKET BY CELL SIGNALLING PATHWAYS/SIGNAL TRANSDUCTION 2014-2022 ($ MILLION)
4.3. BY END USERS
4.3.1. GLOBAL CELL AND TISSUE TECHNOLOGIES MARKET BY CELL CULTURE COLLECTION REPOSITORIES 2014-2022 ($ MILLION)
4.3.2. GLOBAL CELL AND TISSUE TECHNOLOGIES MARKET BY CONTRACT RESEARCH ORGANIZATIONS (CROS) AND PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES 2014-2022 ($ MILLION)
4.3.3. GLOBAL CELL AND TISSUE TECHNOLOGIES MARKET BY LABORATORIES 2014-2022 ($ MILLION)
4.3.4. GLOBAL CELL AND TISSUE TECHNOLOGIES MARKET BY HOSPITALS AND ACADEMIC & RESEARCH INSTITUTES 2014-2022 ($ MILLION)
4.3.5. GLOBAL CELL AND TISSUE TECHNOLOGIES MARKET BY OTHER END USERS 2014-2022 ($ MILLION)
5. GEOGRAPHICAL TECHNOLOGIES
5.1. NORTH AMERICA CELL AND TISSUE TECHNOLOGIES MARKET 2014-2022($MILLION)
5.1.1. UNITED STATES (U.S.) CELL AND TISSUE TECHNOLOGIES MARKET 2014-2022($MILLION)
5.1.2. CANADA CELL AND TISSUE TECHNOLOGIES MARKET 2014-2022($MILLION)
5.2. EUROPE CELL AND TISSUE TECHNOLOGIES MARKET 2014-2022($MILLION)
5.2.1. UNITED KINGDOM (UK) CELL AND TISSUE TECHNOLOGIES MARKET 2014-2022($MILLION)
5.2.2. FRANCE CELL AND TISSUE TECHNOLOGIES MARKET 2014-2022($MILLION)
5.2.3. GERMANY CELL AND TISSUE TECHNOLOGIES MARKET 2014-2022($MILLION)
5.2.4. SPAIN CELL AND TISSUE TECHNOLOGIES MARKET 2014-2022($MILLION)
5.2.5. ITALY CELL AND TISSUE TECHNOLOGIES MARKET 2014-2022($MILLION)
5.2.6. ROE MARKET 2014-2022($MILLION)
5.3. ASIA PACIFIC CELL AND TISSUE TECHNOLOGIES MARKET 2014-2022($MILLION)
5.3.1. INDIA CELL AND TISSUE TECHNOLOGIES MARKET 2014-2022($MILLION)
5.3.2. CHINA CELL AND TISSUE TECHNOLOGIES MARKET 2014-2022($MILLION)
5.3.3. JAPAN CELL AND TISSUE TECHNOLOGIES MARKET 2014-2022($MILLION)
5.3.4. KOREA CELL AND TISSUE TECHNOLOGIES MARKET 2014-2022($MILLION)
5.3.5. AUSTRALIA CELL AND TISSUE TECHNOLOGIES MARKET 2014-2022($MILLION)
5.3.6. ROAPAC CELL AND TISSUE TECHNOLOGIES MARKET 2014-2022($MILLION)
5.4. REST OF THE WORLD CELL AND TISSUE TECHNOLOGIES MARKET 2014-2022($MILLION)
5.4.1. LATIN AMERICA CELL AND TISSUE TECHNOLOGIES MARKET 2014-2022($MILLION)
5.4.2. MENA CELL AND TISSUE TECHNOLOGIES MARKET 2014-2022($MILLION)
5.4.3. AFRICA CELL AND TISSUE TECHNOLOGIES MARKET 2014-2022($MILLION)
6. COMPANY PROFILES
AGILENT TECHNOLOGIES, INC.
BECTON, DICKINSON AND COMPANY
BIO-RAD LABORATORIES
DANAHER CORPORATION
FLUIDIGM CORPORATION
GE HEALTHCARE
MERCK KGAA
NANOSTRING TECHNOLOGIES, INC.
OLYMPUS CORPORATION
PERKINELMER, INC.
PROMEGA CORPORATION
QIAGEN N.V.
SIGMA ALDRICH CORPORATION
TECAN GROUP LTD.
THERMO FISHER SCIENTIFIC, INC.
LIST OF TABLE
GLOBAL CELL AND TISSUE TECHNOLOGIES MARKET BY PRODUCT ($ MILLION)
GLOBAL CELL AND TISSUE TECHNOLOGIES MARKET BY CONSUMABLES ($ MILLION)
GLOBAL CELL AND TISSUE TECHNOLOGIES MARKET BY REAGENTS ($ MILLION)
GLOBAL CELL AND TISSUE TECHNOLOGIES MARKET BY ASSAY KITS ($ MILLION)
GLOBAL CELL AND TISSUE TECHNOLOGIES MARKET BY IMMUNOASSAYS ($ MILLION)
GLOBAL CELL AND TISSUE TECHNOLOGIES MARKET BY CELL-BASED ASSAYS ($ MILLION)
GLOBAL CELL AND TISSUE TECHNOLOGIES MARKET BY MICROPLATES ($ MILLION)
GLOBAL CELL AND TISSUE TECHNOLOGIES MARKET BY OTHER CONSUMABLES ($ MILLION)
GLOBAL CELL AND TISSUE TECHNOLOGIES MARKET BY INSTRUMENTS ($ MILLION)
GLOBAL CELL AND TISSUE TECHNOLOGIES MARKET BY MICROSCOPES ($ MILLION)
GLOBAL CELL AND TISSUE TECHNOLOGIES MARKET BY ELECTRON MICROSCOPES ($ MILLION)
GLOBAL CELL AND TISSUE TECHNOLOGIES MARKET BY INVERTED MICROSCOPES ($ MILLION)
GLOBAL CELL AND TISSUE TECHNOLOGIES MARKET BY STEREO MICROSCOPES ($ MILLION)
GLOBAL CELL AND TISSUE TECHNOLOGIES MARKET BY FLUORESCENCE AND CONFOCAL MICROSCOPES ($ MILLION)
GLOBAL CELL AND TISSUE TECHNOLOGIES MARKET BY PHASE CONTRAST MICROSCOPES ($ MILLION)
GLOBAL CELL AND TISSUE TECHNOLOGIES MARKET BY NEAR-FIELD SCANNING OPTICAL MICROSCOPES (NSOM) ($ MILLION)
GLOBAL CELL AND TISSUE TECHNOLOGIES MARKET BY OTHER MICROSCOPES ($ MILLION)
GLOBAL CELL AND TISSUE TECHNOLOGIES MARKET BY FLOW CYTOMETRY ($ MILLION)
GLOBAL CELL AND TISSUE TECHNOLOGIES MARKET BY FLOW CYTOMETRY SOFTWARE ($ MILLION)
GLOBAL CELL AND TISSUE TECHNOLOGIES MARKET BY FLOW CYTOMETRY INSTRUMENTS ($ MILLION)
GLOBAL CELL AND TISSUE TECHNOLOGIES MARKET BY SPECTROPHOTOMETERS ($ MILLION)
GLOBAL CELL AND TISSUE TECHNOLOGIES MARKET BY MICROPLATE SPECTROPHOTOMETERS ($ MILLION)
GLOBAL CELL AND TISSUE TECHNOLOGIES MARKET BY COLORIMETERS ($ MILLION)
GLOBAL CELL AND TISSUE TECHNOLOGIES MARKET BY FLUORESCENCE MICROPLATE READERS ($ MILLION)
GLOBAL CELL AND TISSUE TECHNOLOGIES MARKET BY QPCR ($ MILLION)
GLOBAL CELL AND TISSUE TECHNOLOGIES MARKET BY CELL COUNTERS ($ MILLION)
GLOBAL CELL AND TISSUE TECHNOLOGIES MARKET BY HEMOCYTOMETERS AND MANUAL CELL COUNTERS ($ MILLION)
GLOBAL CELL AND TISSUE TECHNOLOGIES MARKET BY AUTOMATED CELL COUNTERS ($ MILLION)
GLOBAL CELL AND TISSUE TECHNOLOGIES MARKET BY HIGH-CONTENT SCREENING (HCS) SYSTEMS ($ MILLION)
GLOBAL CELL AND TISSUE TECHNOLOGIES MARKET BY HCS SOFTWARE ($ MILLION)
GLOBAL CELL AND TISSUE TECHNOLOGIES MARKET BY CELL IMAGING AND TECHNOLOGIES HCS SYSTEMS ($ MILLION)
GLOBAL CELL AND TISSUE TECHNOLOGIES MARKET BY CELL MICROARRAYS ($ MILLION)
GLOBAL CELL AND TISSUE TECHNOLOGIES MARKET BY PROCESS ($ MILLION)
GLOBAL CELL AND TISSUE TECHNOLOGIES MARKET BY SINGLE-CELL TECHNOLOGIES ($ MILLION)
GLOBAL CELL AND TISSUE TECHNOLOGIES MARKET BY TARGET IDENTIFICATION AND VALIDATION ($ MILLION)
GLOBAL CELL AND TISSUE TECHNOLOGIES MARKET BY CELL STRUCTURE STUDY ($ MILLION)
GLOBAL CELL AND TISSUE TECHNOLOGIES MARKET BY CELL INTERACTION ($ MILLION)
GLOBAL CELL AND TISSUE TECHNOLOGIES MARKET BY CELL COUNTING AND QUALITY CONTROL ($ MILLION)
GLOBAL CELL AND TISSUE TECHNOLOGIES MARKET BY CELL PROLIFERATION ($ MILLION)
GLOBAL CELL AND TISSUE TECHNOLOGIES MARKET BY CELL SIGNALING PATHWAYS/SIGNAL TRANSDUCTION ($ MILLION)
GLOBAL CELL AND TISSUE TECHNOLOGIES MARKET BY END USERS ($ MILLION)
GLOBAL CELL AND TISSUE TECHNOLOGIES MARKET BY CELL CULTURE COLLECTION REPOSITORIES ($ MILLION)
GLOBAL CELL AND TISSUE TECHNOLOGIES MARKET BY CONTRACT RESEARCH ORGANIZATIONS (CROS) AND PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES ($ MILLION)
GLOBAL CELL AND TISSUE TECHNOLOGIES MARKET BY LABORATORIES ($ MILLION)
GLOBAL CELL AND TISSUE TECHNOLOGIES MARKET BY HOSPITALS AND ACADEMIC & RESEARCH INSTITUTES ($ MILLION)
GLOBAL CELL AND TISSUE TECHNOLOGIES MARKET BY OTHER END USERS ($ MILLION)
LIST OF FIGURES
GLOBAL CELL AND TISSUE TECHNOLOGIES MARKET BY PRODUCT ($ MILLION)
GLOBAL CELL AND TISSUE TECHNOLOGIES MARKET BY CONSUMABLES ($ MILLION)
GLOBAL CELL AND TISSUE TECHNOLOGIES MARKET BY REAGENTS ($ MILLION)
GLOBAL CELL AND TISSUE TECHNOLOGIES MARKET BY ASSAY KITS ($ MILLION)
GLOBAL CELL AND TISSUE TECHNOLOGIES MARKET BY IMMUNOASSAYS ($ MILLION)
GLOBAL CELL AND TISSUE TECHNOLOGIES MARKET BY CELL-BASED ASSAYS ($ MILLION)
GLOBAL CELL AND TISSUE TECHNOLOGIES MARKET BY MICROPLATES ($ MILLION)
GLOBAL CELL AND TISSUE TECHNOLOGIES MARKET BY OTHER CONSUMABLES ($ MILLION)
GLOBAL CELL AND TISSUE TECHNOLOGIES MARKET BY INSTRUMENTS ($ MILLION)
GLOBAL CELL AND TISSUE TECHNOLOGIES MARKET BY MICROSCOPES ($ MILLION)
GLOBAL CELL AND TISSUE TECHNOLOGIES MARKET BY ELECTRON MICROSCOPES ($ MILLION)
GLOBAL CELL AND TISSUE TECHNOLOGIES MARKET BY INVERTED MICROSCOPES ($ MILLION)
GLOBAL CELL AND TISSUE TECHNOLOGIES MARKET BY STEREO MICROSCOPES ($ MILLION)
GLOBAL CELL AND TISSUE TECHNOLOGIES MARKET BY FLUORESCENCE AND CONFOCAL MICROSCOPES ($ MILLION)
GLOBAL CELL AND TISSUE TECHNOLOGIES MARKET BY PHASE CONTRAST MICROSCOPES ($ MILLION)
GLOBAL CELL AND TISSUE TECHNOLOGIES MARKET BY NEAR-FIELD SCANNING OPTICAL MICROSCOPES (NSOM) ($ MILLION)
GLOBAL CELL AND TISSUE TECHNOLOGIES MARKET BY OTHER MICROSCOPES ($ MILLION)
GLOBAL CELL AND TISSUE TECHNOLOGIES MARKET BY FLOW CYTOMETRY ($ MILLION)
GLOBAL CELL AND TISSUE TECHNOLOGIES MARKET BY FLOW CYTOMETRY SOFTWARE ($ MILLION)
GLOBAL CELL AND TISSUE TECHNOLOGIES MARKET BY FLOW CYTOMETRY INSTRUMENTS ($ MILLION)
GLOBAL CELL AND TISSUE TECHNOLOGIES MARKET BY SPECTROPHOTOMETERS ($ MILLION)
GLOBAL CELL AND TISSUE TECHNOLOGIES MARKET BY MICROPLATE SPECTROPHOTOMETERS ($ MILLION)
GLOBAL CELL AND TISSUE TECHNOLOGIES MARKET BY COLORIMETERS ($ MILLION)
GLOBAL CELL AND TISSUE TECHNOLOGIES MARKET BY FLUORESCENCE MICROPLATE READERS ($ MILLION)
GLOBAL CELL AND TISSUE TECHNOLOGIES MARKET BY QPCR ($ MILLION)
GLOBAL CELL AND TISSUE TECHNOLOGIES MARKET BY CELL COUNTERS ($ MILLION)
GLOBAL CELL AND TISSUE TECHNOLOGIES MARKET BY HEMOCYTOMETERS AND MANUAL CELL COUNTERS ($ MILLION)
GLOBAL CELL AND TISSUE TECHNOLOGIES MARKET BY AUTOMATED CELL COUNTERS ($ MILLION)
GLOBAL CELL AND TISSUE TECHNOLOGIES MARKET BY HIGH-CONTENT SCREENING (HCS) SYSTEMS ($ MILLION)
GLOBAL CELL AND TISSUE TECHNOLOGIES MARKET BY HCS SOFTWARE ($ MILLION)
GLOBAL CELL AND TISSUE TECHNOLOGIES MARKET BY CELL IMAGING AND TECHNOLOGIES HCS SYSTEMS ($ MILLION)
GLOBAL CELL AND TISSUE TECHNOLOGIES MARKET BY CELL MICROARRAYS ($ MILLION)
GLOBAL CELL AND TISSUE TECHNOLOGIES MARKET BY PROCESS ($ MILLION)
GLOBAL CELL AND TISSUE TECHNOLOGIES MARKET BY SINGLE-CELL TECHNOLOGIES ($ MILLION)
GLOBAL CELL AND TISSUE TECHNOLOGIES MARKET BY TARGET IDENTIFICATION AND VALIDATION ($ MILLION)
GLOBAL CELL AND TISSUE TECHNOLOGIES MARKET BY CELL STRUCTURE STUDY ($ MILLION)
GLOBAL CELL AND TISSUE TECHNOLOGIES MARKET BY CELL INTERACTION ($ MILLION)
GLOBAL CELL AND TISSUE TECHNOLOGIES MARKET BY CELL COUNTING AND QUALITY CONTROL ($ MILLION)
GLOBAL CELL AND TISSUE TECHNOLOGIES MARKET BY CELL PROLIFERATION ($ MILLION)
GLOBAL CELL AND TISSUE TECHNOLOGIES MARKET BY CELL SIGNALING PATHWAYS/SIGNAL TRANSDUCTION ($ MILLION)
GLOBAL CELL AND TISSUE TECHNOLOGIES MARKET BY END USERS ($ MILLION)
GLOBAL CELL AND TISSUE TECHNOLOGIES MARKET BY CELL CULTURE COLLECTION REPOSITORIES ($ MILLION)
GLOBAL CELL AND TISSUE TECHNOLOGIES MARKET BY CONTRACT RESEARCH ORGANIZATIONS (CROS) AND PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES ($ MILLION)
GLOBAL CELL AND TISSUE TECHNOLOGIES MARKET BY LABORATORIES ($ MILLION)
GLOBAL CELL AND TISSUE TECHNOLOGIES MARKET BY HOSPITALS AND ACADEMIC & RESEARCH INSTITUTES ($ MILLION)
GLOBAL CELL AND TISSUE TECHNOLOGIES MARKET BY OTHER END USERS 2014-2022 ($ MILLION)

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report